ETX0282 is an orally available, broad spectrum inhibitor of class A and C β-lactamases. Entasis is developing ETX0282 in combination with cefpodoxime proxetil, an orally available cephalosporin approved for treatment of a variety of bacterial infections.
河北唯特医药科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
河北唯特医药